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                           Myocardial infarction is a common presentation of ischemic heart 
disease. Ischemic  heart  disease  is  the  leading  cause  of  death  in  developed 
countries,  but  third  to AIDS and lower  respiratory  infections in  developing 
countries.  
                           In India, cardiovascular disease (CVD) is the leading cause of 
death. The deaths due to CVD in India were 32% of all deaths in 2007 and are 
expected to rise from 1.17 million in 1990 and 1.59 million in 2000 to 2.03 million 
in 2010.  Although a relatively new epidemic in India, it  has quickly become a 
major health issue with deaths due to CVD expected to double during 1985-2015.
[ Mortality  estimates  due  to  CVD vary  widely  by  state,  ranging  from 10% in 
Meghalaya to 49% in Punjab (percentage of all deaths). Punjab (49%), Goa (42%), 
Tamil  Nadu  (36%)  and  Andhra  Pradesh  (31%)  have  the  highest  CVD related 
mortality  estimates. State-wise  differences  are  correlated  with  prevalence  of 
specific dietary risk factors in the states. Moderate physical exercise is associated 
with reduced incidence of CVD in India (those who exercise have less than half the 
-
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risk of those who don't). CVD also affects Indians at a younger age (in their 30s 
and 40s) than is typical in other countries.
                        QTc dispersion is an important marker that reflect variations of 
ventricular  repolarisation  and arrythmogenic   potential.  This  study  is  based  on 
various  studies  suggesting  significant  reduction  in  QTc  dispersion  after 
thrombolytic therapy in acute myocardial infarction.
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REVIEW OF LITERATURE   
 MYOCARDIAL INFARCTION  
 Classification
There are two basic types of acute myocardial infarction, (1) transmural MI- is 
associated  with  atherosclerosis  involving  major  coronary  artery.  It  can  be 
subclassified into anterior,posterior  or  inferior.  (2)  subendocardial  MI-  involves 
small  area,  in  the subendocardial  wall  of  the left  ventricle,  ventricular  septum, 
papillary muscles.Clinically, myocardial infarction is further sub classified into ST 
elevation MI verses non ST elevation MI based on ECG changes.
                                    Signs and symptoms
The onset  of  symptoms in  myocardial  infarction  (MI)  is  usually  gradual,  over 
several  minutes,  and  rarely  instantaneous. Chest  pain is  the  most  common 
symptom of acute myocardial infarction and is often described as a sensation of 
tightness, pressure, or squeezing. Chest pain due to ischemia (a lack of blood and 
hence oxygen supply) of the heart muscle is termed angina pectoris. Pain radiates 
most  often  to  the  left arm,  but  may  also  radiate  to  the  lower jaw, neck,  right 
arm, back, and epigastrium, where it may mimic heartburn. Levine's sign, in which 
the patient localizes the chest pain by clenching their fist over the  sternum, has 
classically been thought to be predictive of cardiac chest pain.
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,Shortness  of  breath  (dyspnea)  occurs  when  the  damage  to  the  heart  limits 
the output of  the left  ventricle,  causing left  ventricular  failure and 
consequent pulmonary edema. Other symptoms include diaphoresis (an excessive 
form of sweating), weakness, light-headedness, nausea, vomiting, and palpitations. 
These symptoms are likely induced by a massive surge of catecholamine’s  from 
the sympathetic  nervous  system, which  occurs  in  response  to  pain  and  the 
hemodynamic  abnormalities  that  result  from  cardiac  dysfunction. Loss  of 
consciousness (due to inadequate cerebral perfusion and cardiogenic shock) and 
even  sudden death (frequently due to the development of ventricular fibrillation) 
can occur in myocardial infarctions.
Women and older  patients  experience  atypical  symptoms more  frequently  than 
their male and younger counterparts.  Women also have more symptoms compared   
to men (2.6 on average vs. 1.8 symptoms in men).    The most common symptoms   
of  MI  in  women  include   dyspnea  ,  weakness,  and fatigue.  Fatigue,  sleep 
disturbances, and dyspnea have been reported as frequently occurring symptoms 
which may manifest as long as one month before the actual clinically manifested 
ischemic  event.  In  women, chest  pain may  be  less  predictive  of 
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coronary ischemia than  in  men.  Approximately  half  of  all  MI  patients  have 
experienced warning symptoms such as chest pain prior to the infarction. 
y
Approximately one fourth of all myocardial infarctions are silent, without chest 
pain or other symptoms. These cases can be discovered later on electrocardiograms 
or at autopsy without a prior history of related complaints. A silent course is more 
common  in  the   elderly  ,  in  patients  with diabetes  mellitus     and  after   heart   
transplantation, probably because the donor heart is not connected to nerves of the 
host. In  diabetics,  differences  in pain  threshold, autonomic  neuropathy,  and 
psychological factors  have  been  cited  as  possible  explanations  for  the  lack  of 
symptoms. 
Any groups of symptoms compatible with a sudden interruption of the blood flow 
to the heart are called an acute coronary syndrome. 
The differential  diagnosis includes other  catastrophic  causes  of  chest  pain,  such 
as pulmonary  embolism, aortic  dissection, pericardial  effusion causing cardiac 
tamponade, tension pneumothorax, and esophageal rupture. 
Causes and risk factors
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Heart  attack  rates  are  higher  in  association  with  intense  exertion,  be 
it psychological  stress or physical exertion,  especially  if  the  exertion  is  more 
intense than the individual usually performs.  Quantitatively, the period of intense   
exercise  and  subsequent  recovery  is  associated  with  about  a  6-fold  higher 
myocardial infarction rate (compared with other more relaxed time frames) for 
v
people who are physically very fit. For those in poor physical condition, the rate   
differential is over 35-fold higher.    One observed mechanism for this phenomenon   
is the increased arterial pulse pressure stretching and relaxation of arteries with 
each  heart  beat  which,  as  has  been  observed  with   intravascular  ultrasound  , 
increases  mechanical  "shear  stress"  on atheromas and  the  likelihood  of  plaque 
rupture.Acute severe  infection,  such  as pneumonia,  can  trigger  myocardial 
infarction.  A  more  controversial  link  is  that  between Chlamydophila 
pneumoniae infection and atherosclerosis.  
There is an association of an increased incidence of a heart attack in the morning 
hours,  more  specifically  around  9  a.m.   Some  investigators  theorize  that  this 
increased incidence may be related to the circadian variation in cortisol production 




Risk factors for atherosclerosis are generally risk factors for myocardial infarction:
 Diabetes   (with or without insulin resistance) - the single most important 
risk factor for ischemic heart disease (IHD)
 Tobacco smoking  
 Hypercholesterolemia   (more accurately hyperlipoproteinemia,  especially 
high low density lipoprotein and low high density lipoprotein)
 High blood pressure  
 Family history of ischemic heart disease (IHD)
 Obesity   (defined  by  a body  mass  index of  more  than  30 kg/m²,  or 
alternatively by waist circumference or waist-hip ratio).
 Old age  
 Hyperhomocysteinemia   (high homocysteine,  a  toxic  blood amino 
acid that is elevated when intakes of vitamins B2, B6, B12 and folic acid 
are insufficient)
 Stress   (occupations  with  high  stress  index  are  known  to  have 
susceptibility  for atherosclerosis)
Males are more at risk than females. 
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Women who use combined oral contraceptive pills have a modestly increased risk 
of myocardial infarction, especially in the presence of other risk factors, such as 
smoking. 
Inflammation is known to be an important step in the process of atherosclerotic 
plaque formation.  C-reactive  protein (CRP)  is  a  sensitive  but  non-
specific marker for inflammation. Elevated CRP blood levels, especially measured 
with  high  sensitivity  assays,  can  predict  the  risk  of  MI,  as  well  as stroke and 
development of diabetes.   
p
Inflammation  in periodontal disease  may  be  linked  coronary  heart  disease,  and 
since periodontitis is very common, this could have great consequences for public 
health.  
Baldness, hair  graying,  a  diagonal earlobe  crease (Frank's  sign     )  and  possibly 
other skin features have been suggested as independent risk factors for MI.  Their 
role remains controversial; a common denominator of these signs and the risk of 
MI is supposed, possibly genetic.  
Calcium deposition is another  part  of atherosclerotic plaque formation.  Calcium 
deposits in the coronary arteries can be detected with CT scans. Several studies 
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have shown that coronary calcium can provide predictive information beyond that 
of classical risk factors.  
Pathophysiology
A myocardial infarction occurs when an atherosclerotic plaque slowly builds up in 
the inner lining of a coronary artery and then suddenly ruptures, totally occluding 
the artery and preventing blood flow downstream.   
Acute myocardial infarction refers to two subtypes of acute coronary syndrome, 
namely non-ST-elevated  myocardial  infarction and ST-elevated  myocardial 
infarction, which are most frequently (but not always) a manifestation of coronary 
artery disease. The most common triggering event is the disruption of 
an atherosclerotic plaque in an epicardial coronary artery, which leads to a clotting 
cascade, sometimes resulting in total occlusion of the artery. Atherosclerosis is the 
gradual  buildup  of cholesterol and  fibrous  tissue  in  plaques  in  the  wall 
of arteries (in this case, the coronary arteries), typically over decades. Blood stream 
column irregularities visible on angiography reflect  artery lumen narrowing as a 
result  of  decades  of  advancing  atherosclerosis.  Plaques  can  become  unstable, 
rupture, and additionally promote a thrombus (blood clot) that occludes the artery; 
this  can occur in minutes.  When a  severe enough plaque rupture occurs in the 
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coronary vasculature,  it  leads to myocardial  infarction (necrosis of downstream 
myocardium).
If impaired blood flow to the heart lasts long enough, it triggers a process called 
the ischemic cascade; the heart cells in the territory of the occluded coronary artery 
die (chiefly through necrosis) and do not grow back. A collagen scar forms in its 
place. Recent studies indicate that another form of cell death called apoptosis also 
plays a role in the process of tissue damage subsequent to myocardial infarction. 
As  a  result,  the  patient's  heart  will  be  permanently  damaged.  Myocardial 
scarring also puts the patient at risk for potentially life threatening arrhythmias, and 
may  result  in  the  formation  of  a ventricular  aneurysm that  can  rupture  with 
catastrophic consequences.
K
Injured heart tissue conducts electrical impulses more slowly than normal heart 
tissue. The difference in conduction velocity between injured and uninjured tissue 
can trigger re-entry or a feedback loop that is believed to be the cause of many 
lethal arrhythmias. The most serious of these arrhythmias is ventricular fibrillation, 
an extremely fast  and chaotic heart rhythm that  is  the leading cause of sudden 
cardiac  death.  Another  life  threatening  arrhythmia  is ventricular  tachycardia , 
which  may  or  may  not  cause  sudden  cardiac  death.  However,  ventricular 
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tachycardia usually results in rapid heart rates that prevent the heart from pumping 
blood effectively. Cardiac output and blood pressure may fall to dangerous levels, 
which can lead to further coronary ischemia and extension of the infarct.
The cardiac  defibrillator is  a  device  that  was  specifically  designed  to  terminate 
these potentially fatal arrhythmias. The device works by delivering an electrical 
shock to the patient in order to depolarize a critical mass of the heart muscle, in 
effect  "rebooting"  the  heart.  This  therapy  is  time  dependent,  and  the  odds  of 
successful defibrillation decline rapidly after the onset of cardiopulmonary arrest.
Diagnosis
1
The diagnosis of myocardial infarction is made by integrating the history of the 
presenting  illness  and  physical  examination  with  electrocardiogram findings 
and cardiac  markers (blood  tests for heart  muscle cell damage).A coronary 
angiogram allows  visualization  of   narrowing’s   or  obstructions  on  the  heart 
vessels, and therapeutic measures can follow immediately 
16
A chest  radiograph and  routine  blood  tests  may  indicate  complications  or 
precipitating  causes  and  are  often  performed  upon  arrival  to  an  emergency 
department.  New regional  wall  motion  abnormalities  on  an echocardiogram are 
also suggestive of a myocardial infarction. Echo may be performed in equivocal 
cases by the on-call cardiologist.  In stable patients whose symptoms have resolved 
by  the  time  of  evaluation,technetium-99m  2-methoxyisobutylisonitrile (Tc99m 
MIBI) or thallium-201 chloride can be used in nuclear medicine to visualize areas 
of  reduced  blood  flow  in  conjunction  with  physiologic  or  pharmacologic 
stress. Thallium may also be used to determine viability of tissue, distinguishing 
whether  non-functional  myocardium  is  actually  dead  or  merely  in  a  state  of 
hibernation or of being stunned. 
Diagnostic criteria
 
WHO criteria have classically been used to diagnose MI; a patient is diagnosed 
with myocardial infarction if two (probable) or three (definite) of the following 
criteria are satisfied:
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1. Clinical history of ischaemic type chest pain lasting for more than 20 
minutes
2. Changes in serial ECG tracings
3. Rise and fall of serum cardiac biomarkers such as creatine kinase-MB 
fraction and troponin
The  WHO  criteria  were  refined  in  2000  to  give  more  prominence  to  cardiac 
biomarkers.  According to the new guidelines, a cardiac   troponin   rise accompanied 
by either typical symptoms, pathological Q waves, ST elevation or depression or 
coronary intervention are diagnostic of MI.
Physical examination
The  general  appearance  of  patients  may  vary  according  to  the  experienced 
symptoms; the patient may be comfortable, or restless and in severe distress with 
an  increased respiratory  rate.  A  cool  and pale  skin is  common  and  points 
to vasoconstriction.  Some  patients  have  low-grade  fever  (38–39  °C). Blood 
pressure may be elevated or decreased, and the pulse can be become irregular. 
,
If heart failure ensues, elevated jugular venous pressure and hepatojugular reflux, 
or  swelling  of  the  legs  due  to  peripheral edema may  be  found  on  inspection. 
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Rarely, a cardiac bulge with a pace different from the pulse rhythm can be felt 
on precordial  examination.  Various  abnormalities  can  be  found  on auscultation, 
such as a third and fourth heart sound, systolic murmurs, paradoxical splitting of 
the second heart sound, a pericardial friction rub and rales over the lung. 
Electrocardiogram 
The  primary  purpose  of  the electrocardiogram is  to  detect ischemia or  acute 
coronary  injury  in  broad,  symptomatic emergency  department populations. 
However, the standard 12 lead ECG has several limitations. An ECG represents a 
brief sample in time. Because unstable ischemic syndromes have rapidly changing 
supply versus demand characteristics, a single ECG may not accurately represent 
the  entire  picture.  It  is  therefore  desirable  to  obtain serial 12  lead  ECGs, 
particularly if the first ECG is obtained during a pain-free episode. Alternatively, 
many emergency  departments and chest  pain  centers use  computers  capable  of 
continuous  ST segment  monitoring.   The  standard  12  lead  ECG also  does  not   
directly  examine  the   right  ventricle  ,  and  is  relatively  poor  at  examining  the 
posterior basal and lateral walls of the left ventricle. In particular, acute myocardial 
infarction  in  the  distribution  of  the  circumflex  artery  is  likely  to  produce  a 
nondiagnostic ECG. The use of additional ECG leads like right-sided leads V3R 
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and V4R and posterior leads V7, V8, and V9 may improve sensitivity for right 
ventricular and posterior myocardial infarction. In spite of these limitations, the 12 
lead ECG stands at the center of risk stratification for the patient with suspected 
acute myocardial infarction. Mistakes in interpretation are relatively common, and 
the failure to identify high risk features has a negative effect on the quality of 
patient care. 
The 12 lead ECG is used to classify patients into one of three groups: 
1. those  with  ST  segment  elevation  or  new  bundle  branch  block 
(suspicious  for  acute  injury  and  a  possible  candidate  for  acute 
reperfusion therapy with thrombolytics or primary PCI),
2. those with ST segment depression or T wave inversion (suspicious for 
ischemia), and
3. those with a so-called non-diagnostic or normal ECG.
A  normal  ECG does  not  rule  out  acute  myocardial  infarction.  Sometimes  the 
earliest  presentation  of  acute  myocardial  infarction  is  the  hyperacute  T  wave, 
which is treated the same as ST segment elevation.  In practice this is rarely seen,   
because it only exists for 2–30 minutes after the onset of infarction. Hyperacute T 
waves  need  to  be  distinguished  from  the  peaked  T  waves  associated  with 
hyperkalemia.  The current guidelines for the ECG diagnosis of acute myocardial  
,
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infarction require at  least  1 mm (0.1 mV) of ST segment elevation in the limb 
leads, and at least 2 mm elevation in the precordial leads. These elevations must be 
present in anatomically contiguous leads. (I, aVL, V5, V6 correspond to the lateral 
wall; V1-V4 correspond to the anterior wall; II, III, aVF correspond to the inferior 
wall.) This criterion is problematic, however, as acute myocardial infarction is not 
the most common cause of ST segment elevation in chest pain patients.  Over 90%   
of healthy men have at least 1   mm (0.1 mV) of ST segment elevation in at least   
one precordial lead. The clinician must therefore be well versed in recognizing the 
so-called  ECG  mimics  of  acute  myocardial  infarction,  which  include left 
ventricular  hypertrophy,left  bundle  branch  block, paced  rhythm, early 
repolarization, pericarditis, hyperkalemia, and ventricular aneurysm. 
 Cardiac markers
Cardiac  markers  or  cardiac  enzymes  are  proteins  that  leak  out  of  injured 
myocardial  cells  through  their  damaged  cell  membranes  into  the  bloodstream. 
Until the 1980s, the enzymes SGOT and LDH were used to assess cardiac injury. 
Now, the markers  most  widely  used in  detection of  MI are MB subtype of  the 
enzyme creatine kinase and cardiac troponins T and I as they are more specific for 
myocardial injury. The cardiac troponins T and I which are released within 4–6 
hours of  an attack of  MI and remain  elevated  for  up to  2  weeks,  have nearly 
complete tissue specificity and are now the preferred markers for asssessing 
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myocardial damage.  Elevated  troponins in the setting of chest pain may accurately 
predict  a  high  likelihood  of  a  myocardial  infarction  in  the  near  future.   New   
markers such as   glycogen phosphorylase isoenzyme BB   are under investigation. 
The  diagnosis  of  myocardial  infarction  requires  two  out  of  three  components 
(history, ECG, and enzymes). When damage to the heart occurs, levels of cardiac 
markers rise over time, which is why blood tests for them are taken over a 24-hour 
period.  Because  these  enzyme levels  are  not  elevated  immediately  following a 
heart  attack,  patients  presenting  with  chest  pain  are  generally  treated  with  the 
assumption that a myocardial infarction has occurred and then evaluated for a more 
precise diagnosis. 
 Angiography
 In  difficult  cases  or  in  situations  where  intervention  to  restore  blood  flow is 
appropriate, coronary angiography can be performed. A catheter is inserted into an 
artery (usually the femoral artery) and pushed to the vessels supplying the heart. A 
radio-opaque dye is administered through the catheter and a sequence of x-rays 
(fluoroscopy) is performed. Obstructed or narrowed arteries can be identified, and 
angioplasty applied  as  a  therapeutic  measure  (see  below).  Angioplasty  requires 
extensive skill,  especially in emergency settings. It is performed by a physician 
trained in interventional cardiology.
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h Histopathology  
Histopathological examination of the heart may reveal infarction at autopsy. Under 
the  microscope,  myocardial  infarction  presents  as  a  circumscribed  area  of 
ischemic, coagulative necrosis (cell death). On gross examination, the infarct is not 
identifiable within the first 12 hours. 
Although earlier changes can be discerned using electron microscopy, one of the 
earliest  changes  under  a  normal  microscope  are  so-called wavy  fibers. 
 Subsequently, the myocyte cytoplasm becomes more  eosinophilic (pink) and the 
cells lose their transversal striations, with typical changes and eventually loss of 
the cell  nucleus. The interstitium at the margin of the infarcted area is  initially 
infiltrated  with neutrophils,  then  with lymphocytes and macrophages, 
who phagocytose ("eat") the myocyte debris. The necrotic area is surrounded and 
progressively invaded by granulation tissue, which will replace the infarct with a 
fibrous  (collagenous) scar (which  are  typical  steps  in wound  healing).  The 
interstitial  space  (the  space  between  cells  outside  of  blood  vessels)  may  be 
infiltrated with red blood cells. 
These features can be recognized in cases where the perfusion was not restored; 
reperfused infarcts can have other hallmarks, such as contraction band necrosis. 
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  Prevention
The risk of a recurrent myocardial infarction decreases with strict blood pressure 
management and lifestyle changes, chiefly smoking cessation, regular exercise, a 
sensible diet for patients with heart disease, and limitation of alcohol intake.
Patients are usually commenced on several long-term medications post-MI, with 
the aim of preventing secondary cardiovascular events such as further myocardial 
infarctions, congestive  heart  failure or cerebrovascular  accident (CVA).  Unless 
contraindicated, such medications may include: 
 Antiplatelet  drug   therapy  such  as aspirin and/or clopidogrel should  be 
continued to reduce the risk of plaque rupture and recurrent myocardial 
infarction.  
 Beta  blocker   therapy  such  as metoprolol or carvedilol should  be 
commenced.  These have been particularly beneficial in high-risk patients   
such  as  those  with   left  ventricular   dysfunction  and/or  continuing 
cardiac ischaemia.   β-Blockers  decrease  mortality  and morbidity.  They 
also improve symptoms of cardiac ischemia in NSTEMI.
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 ACE inhibitor   therapy  should  be  commenced  24–48 hours  post-MI  in 
hemodynamically-stable patients, particularly in patients with a history of 
MI, diabetes  mellitus, hypertension, anterior location  of  infarct  (as 
assessed by ECG), and/or evidence of left ventricular dysfunction. ACE 
inhibitors reduce 
 mortality,  the  development  of heart  failure,  and  decrease  ventricular 
remodelling post-MI. 
 Statin   therapy has been shown to reduce mortality and morbidity post-
MI.  The effects of statins may be more than their LDL lowering effects. 
The  general  consensus  is  that  statins  have plaque stabilization  and 
multiple  other  ("pleiotropic")  effects  that  may  prevent  myocardial 
infarction in addition to their effects on blood lipids. 
 The aldosterone  antagonist agent eplerenone has  been  shown  to  further 
reduce risk of cardiovascular death post-MI in patients with heart failure 
and left ventricular dysfunction, when used in conjunction with standard 
therapies above. 
 Omega-3  fatty  acids  ,  commonly  found  in  fish,  have  been  shown  to 
reduce mortality post-MI.   
 Management
A heart attack is a medical emergency which demands both immediate attention 
and  activation  of  the emergency  medical  services.  The  ultimate  goal  of  the 
management in the acute phase of the disease is to salvage as much myocardium as 
possible and prevent further complications. As time passes, the risk of damage to 
the heart muscle increases; hence the phrase that in myocardial infarction, "time is 
muscle," and time wasted is muscle lost. 
Oxygen, aspirin, glyceryl  trinitrate (nitroglycerin)  and analgesia  .  Morphine  is 
classically used if nitroglycerin is not effective due to its ability to dilate blood 
vessels,  which may aids in blood flow to the heart as well  as the pain relief it 
provides.  Morphine  may  also  cause  hypotension  (usually  in  the  setting  of 
hypovolemia), and should be avoided in the case of right ventricular infarction.  
Of the front line agents, aspirin and streptokinase have been shown to markedly 
reduce mortality  . Streptokinase activates plasminogen, which is fibrinolytic (see 
section on thrombolysis below).
Once  the diagnosis  of  myocardial  infarction is  confirmed,  other  pharmacologic 
agents  are  often  given.  These  include beta  blockers,  anticoagulation  (typically 
with heparin),  and possibly additional  antiplatelet agents such as clopidogrel.   
 First aid
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As myocardial infarction is a common medical emergency, the signs are often part 
of first  aid courses.  The emergency  action  principles also  apply  in  the  case  of 
myocardial infarction.
When symptoms of myocardial infarction occur, people wait an average of three 
hours, instead of doing what is recommended: calling for help immediately. 
 Acting  immediately  by  calling  the  emergency  services  can  prevent  sustained 
damage to the heart ("time is muscle"). 
Certain positions allow the patient to rest in a position which minimizes breathing 
difficulties. A half-sitting position with knees bent is often recommended. Access 
to more oxygen can be given by opening the window and widening the collar for 
easier breathing.
Aspirin can be given quickly (if the patient is not allergic to aspirin); but taking 
aspirin  before  calling  the emergency  medical  services may  be  associated  with 
unwanted  delay.   Aspirin  has  an   antiplatelet   effect  which  inhibits  formation  of 
further thrombi (blood clots) that clog arteries. Chewing is the preferred method of 
administration,  so  that  the  Aspirin  can  be absorbed quickly.  Dissolved  soluble 
preparations  or sublingual administration  can  also  be  used.  U.S.  guidelines 
recommend a dose of 162–325 mg.   Australian guidelines recommend a dose of   
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150–300   mg.   Glyceryl trinitrate   (nitroglycerin) sublingually (under the tongue) can 
be given if available.
If  an automated  external  defibrillator (AED)  is  available  the  rescuer  should 
immediately  bring the AED to the patient's  side  and be prepared to  follow its 
instructions, especially should the victim lose consciousness. 
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Other  general  first  aid  principles  include  monitoring  pulse,  breathing, level  of 
consciousness and, if possible, the blood pressure of the patient. In case of cardiac 
arrest, cardiopulmonary resuscitation (CPR) can be administered.
 Automatic external defibrillation (AED)
                           Since the publication of data showing that the availability 
of automated  external  defibrillators (AEDs)  in  public  places  may  significantly 
increase  chances  of  survival,many  of  these  have  been  installed  in  public 
buildings, public  transport facilities,  and  in  non-ambulance  emergency  vehicles 
(e.g. police cars and fire engines). AEDs analyze the heart's rhythm and determine 
whether  the  rhythm  is  amenable  to defibrillation("shockable"),as  in ventricular 
tachycardia and ventricular fibrillation.
Reperfusion
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                     Patients who present with suspected acute myocardial infarction and 
ST  segment  elevation  (STEMI)  or  new  bundle  branch  block  on  the  12 
lead ECG are presumed to have an occlusive thrombosis in an epicardial coronary 
artery.  They  are  therefore  candidates  for  immediate  reperfusion,  either 
with thrombolytic therapy, percutaneous coronary intervention (PCI) or when these 
therapies are unsuccessful, bypass surgery.
 
             Individuals without ST segment elevation are presumed to be experiencing 
either unstable angina (UA) or non-ST segment elevation myocardial infarction 
(NSTEMI). They receive many of the same initial therapies and are often stabilized 
with antiplatelet  drugs and anticoagulated.  If  their  condition  remains 
(hemodynamically)  stable,  they  can  be  offered  either  late coronary 
angiography with subsequent restoration of blood flow (revascularization), or non-
invasive stress  testing to  determine  if  there  is  significant  ischemia  that  would 
benefit from revascularization. If hemodynamic instability develops in individuals 
with NSTEMIs, they may undergo urgent coronary angiography and subsequent 
revascularization. The use of thrombolytic agents is contraindicated in this patient 
subset, however. 
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The basis for this distinction in treatment regimens is that ST segment elevations 
on an ECG are typically due to complete occlusion of a coronary artery. On the 
other hand, in NSTEMIs there is typically a sudden narrowing of a coronary artery 
with preserved (but diminished) flow to the distal myocardium. Anticoagulation 
and antiplatelet agents are given to prevent the narrowed artery from occluding.
At  least  10%  of  patients  with  STEMI  don't  develop  myocardial  necrosis  (as 
evidenced by a rise in cardiac markers) and subsequent Q waves on ECG after 
reperfusion therapy. Such a successful restoration of flow to the infarct-related 
artery during an acute myocardial infarction is known as "aborting" the myocardial 
infarction. If treated within the hour, about 25% of STEMIs can be aborted. 
 Thrombolytic therapy 
Thrombolytic therapy is indicated for the treatment of STEMI if the drug can be 
administered  within  12  hours  of  the  onset  of  symptoms,  the  patient  is  eligible 
based on exclusion criteria,  and primary PCI is not immediately available. The 
effectiveness of thrombolytic therapy is highest in the first 2 hours. After 12 hours, 
the  risk  associated  with  thrombolytic  therapy  outweighs  any  benefit.   Because 
irreversible  injury  occurs  within 2–4 hours of  the infarction,  there  is  a  limited 
window of time available for reperfusion to work.
30
                 Thrombolytic drugs are contraindicated for the treatment of unstable 
angina  and  NSTEMI   and  for  the  treatment  of  individuals  with  evidence 
of cardiogenic  shock. Although  no  perfect  thrombolytic  agent  exists,  an  ideal 
thrombolytic drug would lead to rapid reperfusion, have a high sustained patency 
rate, be specific for recent thrombi, be easily and rapidly administered, create a low 
risk  for  intra-cerebral  and  systemic  bleeding,  have  no  antigenicity,  adverse 
hemodynamic  effects,  or  clinically  significant  drug  interactions,  and  be  cost 
effective.  Currently available  thrombolyticagentsinclude streptokinase, urokinase,
 
and alteplase (recombinant tissue  plasminogen  activator,  rtPA).  More  recently, 
thrombolytic  agents  similar  in  structure  to  rtPA  such 
as reteplase and tenecteplase have been used. These newer agents boast efficacy at 
least as good as rtPA with significantly easier administration. The thrombolytic 
agent used in a particular individual is based on institution preference and the age 
of the patient.
         Depending on the thrombolytic agent being used, adjuvant anticoagulation 
with heparin or low molecular  weight  heparin may be of  benefit.  With TPa and 
related agents (reteplase and tenecteplase), heparin is needed to maintain coronary 
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artery patency. Because of the anticoagulant effect of fibrinogen depletion with 
streptokinase and urokinase  treatment, it is less necessary there. 
             Intracranial  bleeding  (ICB)  and  subsequent cerebrovascular 
accident (CVA) is a serious side effect of thrombolytic use. The risk of ICB is 
dependent  on a number  of  factors,  including a previous episode of  intracranial 
bleed, age of the individual, and the thrombolytic regimen that is being used. In 
general,  the  risk of  ICB due to thrombolytic use for  the treatment  of  an acute 
myocardial infarction is between 0.5 and 1 percent. 
          Thrombolytic  therapy to  abort  a  myocardial  infarction is  not  always 
effective. The degree of effectiveness of a thrombolytic agent is dependent on the 
time since the myocardial infarction began, with the best results occurring if the 
thrombolytic  agent  is  used  within  two hours  of  the  onset  of  symptoms. If  the 
individual presents more than 12 hours after symptoms commenced, the risk of 
intracranial bleed are considered higher than the benefits of the thrombolytic agent. 
Failure rates of thrombolytics can be as high as 20% or higher. In cases of failure 
of the thrombolytic agent to open the infarct-related coronary artery, the patient is 
then either treated conservatively with anticoagulants and allowed to "complete the 
infarction" or percutaneous coronary intervention  is then performed. Percutaneous 
coronary intervention in this setting is known as "rescue PCI" or "salvage PCI". 
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Complications, particularly bleeding, are significantly higher with rescue PCI than 
with primary PCI due to the action of the thrombolytic agent.
Percutaneous coronary intervention 
 When performed rapidly by an experienced team, primary PCI restores flow in the 
culprit  artery  in  more  than  95%  of  patients  compared  with  the  spontaneous 
recanalization rate of about 65%.   The use of percutaneous coronary intervention 
as a therapy to abort a myocardial infarction is known as primary PCI. The goal of 
primary PCI is to open the artery as soon as possible, and preferably within 90 
minutes of the patient presenting to the emergency room. This time is referred to as 
the door-to-balloon time.  
Primary  PCI  involves  performing  a  coronary angiogram to  determine  the 
anatomical location of the infarcting vessel, followed by balloon angioplasty (and 
frequently  deployment  of  an  intracoronary  stent)  of  the  thrombosed  arterial 
segment. In some settings, an extraction catheter may be used to attempt to aspirate 
the thrombus prior to balloon angioplasty. While the use of intracoronary stents do 
not  improve  the  short  term  outcomes  in  primary  PCI,  the  use  of  stents  is 
widespread  because  of  the  decreased  rates  of  procedures  to  treat  restenosis 
compared to balloon angioplasty .
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Adjuvant  therapy  during  primary  PCI  include  intravenous heparin, aspirin, 
and clopidogrel.  The use of glycoprotein IIb/IIIa inhibitors are often used in the 
setting of primary PCI to reduce the risk of ischemic complications during the 
procedure.   Due  to  the  number  of  antiplatelet  agents  and  anticoagulants  used 
during primary PCI, the risk of bleeding associated with the procedure are higher 
than during an elective PCI. 
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Coronary artery bypass surgery
Despite the guidelines, emergency bypass surgery for the treatment of an acute 
myocardial infarction (MI) is less common than PCI or medical management.  
Emergency coronary artery bypass graft surgery (CABG) is usually undertaken to 
simultaneously  treat  a  mechanical  complication,  such  as  a  ruptured  papillary 
muscle,  or  a  ventricular  septal  defect,  with  ensueing  cardiogenic  shock.   In   
uncomplicated MI, the   mortality rate   can be high when the surgery is performed 
immediately  following  the  infarction.   If  this  option  is  entertained,  the  patient   
should be stabilized prior to surgery, with supportive interventions such as the use 
of an   intra-aortic balloon pump  .   In patients developing  cardiogenic shock after a 
myocardial infarction, both PCI and CABG are satisfactory treatment options, with 
similar survival rates. 
Coronary artery bypass surgery involves an artery or vein from the patient being 
implanted  to  bypass  narrowings or  occlusions  on the  coronary  arteries.  Several 
arteries  and  veins  can  be  used,  however internal  mammary  artery grafts  have 
demonstrated  significantly  better  long-term  patency  rates  than great  saphenous 
vein grafts.  In patients with two or more coronary arteries affected, bypass surgery   
is  associated  with  higher  long-term   survival  rates   compared  to  percutaneous 
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interventions.   In patients with single vessel disease, surgery is comparably safe   
and effective, and may be a treatment option in selected cases.    Bypass surgery has  
 
higher  costs  initially,  but  becomes cost-effective in  the  long  term.   A  surgical   
bypass graft is more   invasive   initially but bears less risk of recurrent procedures 
(but these may be again minimally invasive). 
Monitoring for arrhythmias
Additional  objectives  are  to  prevent  life-threatening  arrhythmias  or  conduction 
disturbances.  This  requires  monitoring  in  a coronary  care  unit and  protocolised 
administration of antiarrhythmic agents. Antiarrhythmic agents are typically only 
given to individuals with life-threatening arrhythmias after a myocardial infarction 
and not  to  suppress the ventricular  ectopy that  is  often seen  after  a  myocardial 
infarction. 
Rehabilitation
Cardiac  rehabilitation aims  to  optimize  function  and quality  of  life in  those 
afflicted with a heart disease. This can be with the help of a physician, or in the 
form of a cardiac rehabilitation program. 
Physical  exercise is  an  important  part  of rehabilitation after  a  myocardial 
infarction,  with  beneficial  effects  on  cholesterol  levels,  blood  pressure, 
weight, stress and mood.   Some patients  become  afraid  of  exercising  because  it   
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might trigger another infarct.    Patients are stimulated to exercise, and should only   
avoid certain exerting activities   Local authorities may place limitations 
m
on driving motorised  vehicles  Some people  are  afraid  to  have sex after  a  heart 
attack. Most people can resume sexual activities after 3 to 4 weeks. The amount of 
activity needs to be dosed to the patient's possibilities. 
New therapies under investigation
Patients  who  receive stem  cell  treatment by coronary  artery injections  of stem 
cells derived from their own bone marrow after a myocardial infarction (MI) show 
improvements  in  left  ventricular ejection  fraction and end-diastolic  volume not 
seen with placebo. The larger the initial infarct size, the greater the effect of the 
infusion. Clinical trials of progenitor cell infusion as a treatment approach to ST 
elevation MI are proceeding. 
There  are  currently  3 biomaterial and tissue  engineering approaches  for  the 
treatment of MI, but these are in an even earlier stage of medical research, so many 
questions and issues need to be addressed before they can be applied to patients. 
The first  involves polymeric left  ventricular  restraints  in  the prevention of heart 
failure.  The  second  utilizes in  vitro engineered  cardiac  tissue,  which  is 
subsequently implanted in vivo. The final approach entails injecting cells and/or a 
scaffold into the myocardium to create in situ engineered cardiac tissue. 
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 Complications
Complications  may  occur  immediately  following  the  heart  attack  (in 
the acute phase),  or  may  need  time  to  develop  (a chronic problem).  After  an 
infarction, an obvious complication is a second infarction, which may occur in the 
domain of another atherosclerotic coronary artery, or in the same zone if there are 
any live cells left in the infarct.
Congestive heart failure 
A myocardial infarction may compromise the function of the heart as a pump for 
the circulation, a state called heart failure. There are different types of heart failure; 
left- or right-sided (or bilateral) heart failure may occur depending on the affected 
part of the heart, and it is a low-output type of failure. If one of the heart valves is 
affected,  this may cause dysfunction, such as mitral regurgitation in the case of 
left-sided  coronary  occlusion  that  disrupts  the  blood  supply  of  the  papillary 
muscles. The incidence of heart failure is particularly high in patients with diabetes 
and requires special management strategies. 
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Myocardial rupture 
Myocardial rupture is most common three to five days after myocardial infarction, 
commonly of small degree, but may occur one day to three weeks later. In the 
modern era of early revascularization and intensive pharmacotherapy as treatment 
for MI, the incidence of myocardial rupture is about 1% of all  MIs . This may 
occur in the free walls of the ventricles,  the septum between them, the papillary 
muscles, or less commonly the atria. Rupture occurs because of increased pressure 
against the weakened walls of the heart chambers due to heart muscle that cannot 
pump blood out effectively. The weakness may also lead to ventricular aneurysm, 
a localized dilation or ballooning of the heart chamber. 
Rupture is usually a catastrophic event that may result a life-threatening process 
known  as cardiac  tamponade,  in  which  blood  accumulates  within 
the pericardium or heart sac, and compresses the heart to the point where it cannot 
pump effectively. Rupture of the intraventricular septum (the muscle separating the 
left and right ventricles) causes a ventricular septal defect with shunting of blood 
through the defect from the left  side of the heart to the right side of the heart, 
which can lead to right ventricular failure as well as pulmonary overcirculation. 
Rupture of the papillary muscle  may also lead to acute mitral  regurgitation and 
subsequent pulmonary edema and possibly even cardiogenic shock.
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Life-threatening arrhythmia 
Since the electrical characteristics of the infarcted tissue change  arrhythmias are a 
frequent  complication  .   The  re-entry  phenomenon may  cause  rapid heart  rates 
(ventricular  tachycardia and  even ventricular  fibrillation),  and  ischemia  in 
the electrical conduction system of the heart may cause a complete heart 
block (when the impulse from the sinoatrial node, the normal cardiac pacemaker, 
does not reach the heart chambers). 
 Pericarditis 
As a reaction to the damage of the heart muscle, inflammatory cells are attracted. 
The inflammation may reach out and affect the heart sac. This is called pericarditis. 
In Dressler's syndrome, this occurs several weeks after the initial event.
 Cardiogenic shock
A  complication  that  may  occur  in  the  acute  setting  soon  after  a  myocardial 
infarction or in the weeks following it is cardiogenic shock. Cardiogenic shock is 
defined as  a  hemodynamic  state  in  which  the heart  cannot  produce  enough of 
a cardiac output to supply an adequate amount of oxygenated blood to the tissues 
of the body.
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While the data on performing interventions on individuals with cardiogenic shock 
is  sparse,  trial  data  suggests  a  long-term  mortality  benefit  in  undergoing 
revascularization if the individual is less than 75 years old and if the onset of the 
acute  myocardial  infarction is  less  than  36 hours  and the  onset  of  cardiogenic 
shock is less than 18 hours.  If the patient with  cardiogenic shock is not going to be 
revascularized,  aggressive hemodynamic support  is  warranted,  with insertion of 
an intra-aortic balloon pump if not contraindicated.  If diagnostic coronary  
w
angiography does not reveal a culprit blockage that is the cause of the cardiogenic 
shock, the prognosis is poor .
 Prognosis
The prognosis for patients with myocardial infarction varies greatly, depending on 
the patient,  the condition itself  and the given treatment.  Using simple variables 
which are immediately available in the emergency room, patients with a higher risk 
of adverse outcome can be identified. For example, one study found that 0.4% of 
patients with a low risk profile had died after 90 days, whereas the mortality rate in 
high risk patients was 21.1% . 
                                                      Although studies differ in the identified 
variables,  some  of  the  more reproduced risk  stratifiers  include 
age, hemodynamic parameters  (such  as  heart  failure, cardiac  arrest on 
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admission, systolic blood pressure, or Killip class of two or greater), ST-segment 
deviation, diabetes, serum creatinine concentration, peripheral vascular disease and 
elevation of cardiac markers. Assessment of left ventricular ejection fraction may 
increase the predictive power of some risk stratification models.   The prognostic   
importance  of  Q-waves  is  debated.     Prognosis  is  significantly  worsened  if  a   
mechanical complication (  papillary muscle   rupture, myocardial free wall rupture, 
and so on) were to occur. 
 
RELATED STUDIES
1. Reduction in QT interval dispersion by successful thrombolytic therapy in 
acute  myocardial  infarction.  TEAM-2  Study  Investigators FL  Moreno,  T 
Villanueva, LA Karagounis and JL Anderson. Circulation,1994; Vol 90, 94-100 
BACKGROUND:  QT  dispersion  (QTd,  equals  maximal  minus  minimal  QT 
interval) on  a  standard  ECG  has  been  shown  to  reflect  regional  variations 
in ventricular  repolarization  and  is  significantly  greater  in  patients  with than  in 
those without arrhythmic events. METHODS AND RESULTS: To assess the effect 
of thrombolytic therapy on QTd, we studied 244 patients (196 men; mean age, 57 
+/-  10  years)  with  acute  myocardial  infarction  (AMI)  who  were treated  with 
streptokinase (n = 115) or anistreplase (n = 129) at an average of 2.6 hours after 
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symptom onset. Angiograms at 2.4 +/- 1 hours after thrombolytic therapy showed 
reperfusion (TIMI grade > or = 2) in 75% of patients. QT was measured in 10 +/- 2 
leads  at  9  +/-  5  days  after AMI  by  using  a  computerized  analysis  program 
interfaced with a digitizer. QTd, QRSd, JT (QT minus QRS), and JT dispersion 
(JTd, equals maximal minus minimal JT interval) were calculated with a computer. 
There were significant differences in QTd (96 +/- 31, 88 +/- 25, 60 +/- 22, and 52 
+/- 19 milliseconds; P < or = .0001) and in JTd (97 +/- 32, 88 +/- 31, 63 +/- 23, and 
58 +/- 21 milliseconds; P = .0001) but not in QRSd (25 +/- 10, 22 +/- 7, 28 +/- 9, 
and  24  +/-  9  milliseconds;  P  =  .24)  among  perfusion grades  0,  1,  2,  and  3, 
respectively. Similar  results were obtained comparing TIMI grades 0/1 with 2/3 
and  0/1/2  with  3.  Patients  with  left anterior  descending  (versus  right  and  left 
circumflex) coronary artery occlusion showed significantly greater QTd (70 +/- 29 
versus  59  +/-  27 milliseconds,  P = .003)  and JTd (74 +/-  30  versus  63  +/-  27 
milliseconds,  P = .004).  Similarly,  patients  with anterior  (versus inferior/lateral) 
AMIshowed significantly greater QTd (69 +/- 30 versus 59 +/- 27 milliseconds, P = 
.006) and JTd (73 +/- 30 versus 63 +/- 27 milliseconds, P = .007). Results did not 
change when Bazett's QTc or JTc was substituted for QT or JT or when ANOVA 
included adjustments for age, sex, drug assignment, infarct site, infarct vessel, and 
number  of  measurable  leads.  On  ANCOVA, the  relation  of  QTd  or  JTd  and 
perfusion  grade  was  not  influenced  by  heart rate.  CONCLUSIONS:  Successful 
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thrombolysis is associated with less QTd and JTd in post-AMI patients. The results 
are  equally  significant  when  either QT  or  JT  is  used  for  analysis.  These  data 
support the hypothesis that QTd after AMI depends on reperfusion status as well as 
infarct site and size. Reduction in QTd and its corresponding risk of ventricular 
arrhythmia may be mechanisms of benefit of thrombolytic therapy. 
 
2. Charles Antzelevitch et al-      Cardiac repolarization. The long and short of 
it* *Europace20057(s2):S3-S9; ©2005 TheEuropean Society   of   Cardiology.   
Heterogeneity of transmural ventricular repolarization in the heart has been linked 
to  a  variety of arrhythmic  manifestations. Electrical  heterogeneity  in  ventricular 
myocardium  is  due  to ionic  distinctions  among  the  three  principal  cell  types: 
Endocardial, M and Epicardial  cells.  A  reduction  in  net  repolarizing  current 
generally  leads  to  a  preferential  prolongation of the  M cell action  potential.  An 
increase in net repolarizing current can lead to a preferential  abbreviation of the 
action  potential of right  ventricular  epicardium  or  left  ventricular 
endocardium.These  changes  can  result  in  amplification of transmural 
heterogeneities of  repolarization and thus  predispose  to  the 
development of potentially lethal reentrant arrhythmias   
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3.Assessment  of  QT Dispersion for  Prediction of  Mortality  or  Arrhythmic 
Events After Myocardial Infarction Markus Zabel, MD; Thomas Klingenheben, 
MD; Michael R. Franz, MD, PhD; ; Stefan H. Hohnloser, MD
Circulation. 1998;97:2543-2550.)  © 1998 American Heart Association, Inc.  
  In 280 consecutive infarct survivors, the 12-lead ECG was optically scanned and 
digitized for analysis of QTD (QTmax-QTmin) and 25 other repolarization 
variables, including  recently  developed  and  validated  parameters  such  as the  T 
peak–to–T end interval and the area under the T wave. In addition, a variety of 
established risk stratifiers were assessed. After a mean follow-up period of 32±10 
months, 30  patients  reached  one  of  the  prospectively  defined  study  end 
points (death,  ventricular  tachycardia,  or  resuscitated  ventricular fibrillation). 
Comparisons  between  event  and  nonevent  patients by  means  of  Kaplan-Meier 
event probability analyses revealed that none of the ECG dispersion variables were 
of  discriminative value.  In  contrast,  variables  such  as  left  ventricular 
ejection fraction  (P=0.007),  mean  24-hour  heart  rate  (P=0.022),  or  heart rate 
variability (P=0.007) proved to be potentially useful risk stratifiers in this patient 
population.  On  multivariate  analysis, only  LVEF,  heart  rate  variability,  and  a 
history of thrombolysis were independent predictors of outcome.
46
4.Short-and  Long-Term Reproducibility  of  QT,  QTc,  and  QT  Dispersion 
Measurement  in  Healthy  Subjects JOSEF KAUTZNER  , GANG YI  , A. 
JOHN, CAMM, MAREK MALIK  Pacing and Clinical Electrophysiology
Volume 17 Issue 5, Pages 928 - 937 © 2009 Wiley Periodicals, Inc.
    The study investigated interobserver  and intrasubject  reproducibility  of  QT 
interval duration and dispersion measured in standard 12-lead ECGs recorded at 25 
mm/sec. Twenty-eight healthy volunteers were studied. Each undenvent four ECG 
recordings,  which  were  performed  1,  7,  and  30  days  apart.  Two  independent 
observers analyzed each ECG record. In each lead with a distinguishable T wave 
pattern,  the  RR  interval,  Q-peak  of  T  interval,  and  Q-end  of  T  interval  were 
measured using a digitizing board with a 0.1-mm resolution. From each recording 
the  following  measures  were  derived:  the  maximum,  minimum,  and  mean  QT 
interval; maximum, minimum, and mean heart rate corrected QT interval (QTc); 
QT and QTc dispersion (the difference between the maximum and minimum QT 
interval  among the 12 leads);  and adjusted QT and QTc dispersion (dispersion 
divided by the square root of the number of leads measured). The interobserver and 
short-term  (1  day)  and  long-term  (1  week  and  1  month)  reproducibility  of 
individual indices was assessed by computing the relative errors and comparing 
them  by  a  standard  sign  test.  In  addition,  the  distributions  of  maximum  and 
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minimum  QTc  values  among  electrocardiographicleads,  and  the  differences 
between QT-end and QT-peak based measurements were investigated. The results 
showed  that:  (1)  the  measurement  of  the  QT  interval  from  standard  ECG 
recordings  is  feasible  and  not  operator  dependent  (interobserver  relative  error 
<4%); (2) the duration of the QT interval in healthy volunteers is stable and its 
short- and long-term reproducibility is high (intrasubject relative error < 6%); (3) 
parameters that characterize dispersion of the QT interval in the 12-lead ECG are 
highly nonreproducible, both between subsequent recording (relative error of 
25%–35%) and between observers (relative error 28%–33%), the reproducibility of 
QT dispersion is significantly lower than that of QT duration (P < 0.01); and (4) 
the duration of the entire QT interval correlates only weakly with the duration of 
the Q-peak of T interval.
5.QT  Dispersion  and  Early  Arrhythmic  Risk  During  Acute  Myocardial 
Infarction Paventis et al, Angiology, Vol. 50, No. 3, 209-215 (1999) 
  Three hundred three patients with acute myocardial infarction and a control group 
of 297 healthy subjects were studied. QT and QTc dispersion were determined on 
the electrocardiogram taken after 12 hours and on days 3 and 10 after symptoms 
onset and on the electrocardiogram taken in the control group. The average values 
of QT and QTc dispersions (ms) were as follows: 70.5 ±42.5-87 ±45.6 (12th hour), 
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66.7 ±37.6-76.8±43.6 (day 3), 68.8 ±42.7-76.8 ±42.8 (day 10), versus 43 ±13.2- 
53.9 ±16.2 (control group). There were statistically significant differences between 
QT and  QTc  dispersion  recorded  in  normal  subjects  and  in  each  of the  three 
electrocardiograms taken in patients with infarction. A greater QT dispersion was 
recorded  in  patients  with  anterior infarction  (78.9  ±38.5  vs  64.9  ±42.8  in 
inferior/lateral infarction).  In the first  3 days QT dispersion was not  different in 
patients treated and untreated with throm bolysis, whereas on day 10 it was greater 
in untreated patients (74.9 ±45.3 vs 60.5 ±37.2). Creatine kinase peak level did not 
influence QT dispersion. In the first 72 hours of infarction, 37 patients developed 
ventricular fibrillation or sustained ventricular tachy cardia. Higher early values of 
QT and QTc dispersion were found in patients who developed severe ventricular 
arrhythmias (107.8  ±62  and  124.8  ±67.5  ms)  than  in  patients without  serious 
arrhythmias (62.9 ±32.2 and 80.1 ±37.9 ms). 
6.QT  dispersion  as  a  risk  factor  for  sudden  cardiac  death  and  fatal 
myocardial infarction in a coronary risk population.M. Mänttäri, L. Oikarinen, 
V. Manninen, M. Viitasalo Heart 1997;78:268-272  
 At study baseline, QT dispersion was similar in all  victims and controls. When 
estimated from the pre-event ECG on average 14 months before death, the risk of 
sudden  cardiac  death  in  the  highest  QTPEAK (up  to  the  peak  of  the  T  wave) 
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dispersion tertile (> or = 50 ms) was 6.2-fold (95% confidence interval 1.7 to 23.5) 
comparedwith the risk in the lowest tertile (< or = 30 ms), and 4.9-fold (1.2 to 19.5) 
after adjustment for the presence of left ventricular hypertrophy, while QTPEAK 
dispersion could not predict fatalmyocardial infarction. QTEND dispersion (up to 
the end of the T wave) in pre-event ECGs could not discriminate victims of either 
sudden cardiac death or fatal myocardial infarction from their matched controls. 
CONCLUSIONS: In middle aged men with a normal conventional QT interval in 
12-lead resting ECG, increased QTPEAK dispersion is an independent risk factor 
for sudden cardiac death, but not for fatal myocardial infarction.
 
7.QT-interval dispersion in acute myocardial infarction is only shortened by 
thrombolysis in myocardial infarction grade 2/3 reperfusion
 Nikiforos,  Hatzisavvas,   Pavlides, Voudris, Vassilis P. Vassilikos,   Manginas, 
Hatzeioakim, Stefanos Foussas, Iliodromitis, Hatseras, Kremastinos,  Cokkinos,   
Clinical Cardiology  2009 Wiley Periodicals,Inc.
Background: Increased QT interval dispersion (QTd) has been found in patients 
with acute myocardial infarction (AMI). In previous studies this has been shown to 
decrease with thrombolysis.
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Hypothesis: The aim of this study was to compare the effects of reperfusion by 
primary  percutaneous  transluminal  coronary  angioplasty  (PTCA)  and  by 
thrombolysis on QTd and correlate these results with the degree of reperfusion.
Methods: We studied 60 patients with a first AMI. The study cohort included 40 
consecutive patients who had received thrombolysis (streptokinase or rt-PA); 20 
additional consecutive patients with successful primary PTCA, all with preselected 
Thrombolysis  in  Myocardial  Infarction  (TIMI)  grade  3  flow  by  predefined 
selection criteria (12 stents); and 20 controls. A 12-lead ECG for QTd calculation 
was recorded before thrombolysis or PTCA and immediately after the procedure. 
All values were corrected according to Bazett's formula (QTcd). QTd and QTcd 
values before and after each procedure in three groups and the respective percent 
changes of QTd and QTcd were compared separately.
 
Results:  QTd and QTcd were significantly increased before thrombolysis/PTCA 
versus  normals.  An  angiogram performed  after  thrombolysis  showed  adequate 
reperfusion (TIMI grade 2/3) in 20 patients, while in the other 20 only TIMI 0/1 
reperfusion was achieved. Thrombolysis-TIMI flow 2/3 and PTCA significantly 
reduced QTd (from 68 ± 10 to 35 ± 8 ms, p < 0.001, QTd = 48 ± 11%, in the Thr-
TIMI flow 2/3 group, and from 79 ± 11 to 38 ± 9 ms, p < 0.001, QTd = 52 ± 9%, in 
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the PTCA group), while in the Thr-TIMI flow 0/1 group no significant changes 
were  recorded.  A  percent  QTd  decrease  >  30  s  had  96%  sensitivity,  85% 
specificity, and 93% positive and 94% negative predictive value, respectively, for 
TIMI 2/3 flow
 
 8.QT dispersion and early arrhythmic risk during acute myocardial 
infarction.Ciolli A, Di Lorenzo M, Bevilacqua U, Lo Sardo G, Tripi M, Fidati 
R, Palamara A. G Ital Cardiol. 1999 Dec;29(12):1438-44. 
W
 We studied 101 patients with acute myocardial infarction and a control 
group of 97 healthy subjects.  . The average values of QT and QTc 
dispersion (measured hereafter in milliseconds, ms) were as follows: 70.5 
+/- 42.5-87 +/- 46.6 (after 12 hours), 66.5 +/- 37.8-76.9 +/- 43.5 (on day 3), 
68.9 +/- 42-76.3 +/- 43.8 (on day 10) and 44 +/- 13.4-54.2 +/- 16.3 (in 
control group). We observed statistically significant differences in QT and 
QTc dispersion between the electrocardiogram of normal subjects and 
each of the three electrocardiograms performed on patients with infarction 
(p < 0.0005, p < 0.005).  . Creatine kinase peak level, sex and age of the 
patients did not influence QT dispersion. Thirteen patients (12.8%) 
developed severe ventricular arrhythmias within 72 hours after infarction: 8 
patients (7.9%) had ventricular fibrillation and 5 patients (4.9%) had 
sustained ventricular tachycardia. We found higher early QT and QTc 
dispersion values in patients who developed severe ventricular arrhythmias 
(108.8 +/- 63.2 and 125.8 +/- 68.5) with respect to patients who did not 
(63.3 +/- 32.9 and 80.8 +/- 38.9, p < 0.0005, p < 0.0005).  
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sAIMS OF THE STUDY
1.To calculate  the  QT,  QTc,  QTd,  QTcd in  all  patients  with acute  myocardial 
infarction
2.  To  determine  the  difference  of  QT  parameters  in  patients  treated  with 




            102 patients admitted in KAPV Government Medical College Hospital, 
Tiruchirapalli  for Acute Myocardial infarction were taken up for the study. All 
patients were followed for a period of 8±2 days during their stay in the hospital. 
The study group was chosen taking into consideration of the following criteria
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INCLUSION CRITERIA  :
1. Acute Myocardial infarction
  * Chest pain >30 minutes
  * Chest pain not relieved by rest or nitrates
  * ST elevation >1mm or 0.1mv in ≥2 limb leads
     ST elevation >2mm or 0.2mv in ≥  2 precordial leads
  * NSTEMI
2. Treatment with Thrombolytic therapy (streptokinase) / without Thrombolytic 
therapy
4
EXCLUSION CRITERIA  :
1.   The contraindications for thrombolytic therapy for  those patients who were 
treated with thrombolytic therapy
2. Drugs affecting QT interval  eg.Quinidine,procainamide,tricyclics&tetracyclics 
depressants,astemizole,digitalis
3. Hypertrophic cardiomyopathy, Acute carditis
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4. Atrial fibrillation, Bundle branch blocks
5 . Prior coronary bypass surgery
6. Serum potassium  <3.5 mmol/l or > 5.0mmol/l
7. Congenital long QT Syndromes  
 
Jervell-Lange-Neilson Syndrome(deafness,syncope &sudden death with long QT 
interval)
Romano-Ward Syndrome( similar to the above Syndrome but without deafness)
 
e
METHODS In Patients admitted for Acute Myocardial infarction, a standard 12 
lead  ECG  was  taken  at  paper  speed  of  25  mm/s  at  admission  and  before 
discharge(day  8±2).From these  ECG’s  taken  in  all  102  patients  the  following 
parameter were calculated.
1.QT INTERVAL:It was measured from the first deflection of the QRS complex 
to  the point  of  T wave offset,defined by the return of  terminal  T wave to  the 
isoelectric TP baseline. It represents the total duration  of ventricular activity i.e the 
sum of ventricular depolarisation and repolarisation
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2. QTc INTERVAL:QT interval shortens with tachycardia  and lengthens with 
bradycardia. So it  is  corrected using  Bazett’s formula.RR interval is  measured 
between two consecutive R waves.    QTc  =      QT     .    Normal range of QTc is 
0.35 to 0.43 sec                                                 √RR
3.QT  &  QTc  Dispersions:They  are  defined  as  the  difference  between  the 
maximum  and  minimum  QT,QTc  in  each  of  the  12  leads  studied.The  QT 
parameters were correlated   taking into the following variables- site of infarction, 
age  of  the  patient,  diabetes,  HT,  smoking,  alcoholism.  Since the  peak creatine 
kinase level have no correlation with QT parameters ,it was not considered.
TABLES AND CHART
 
TABLE: 1 COMPOSITION OF THE STUDY POPULATION 




SEX TYPE  OF 
INFARCTION
MALE FEMALE STEMI NSTEMI
1) Anterior wall 50 46 4 44 6
2) Extensive anterior 10 10 0 10 0
3) Inferior :
    i) with RVMI

















  iii)Infero lateral 4 4 0 4 0
TOTAL 102 92 10 96 6
TABLE: 2 RISK FACTORS AND MYOCARDIAL INFARCTION





















TOTAL 33 30 37 28
TABLE: 3 QT PARAMETERS AND THROMBOLYSIS
c
TREATMENT AT ADMISSION D8 ± 2
QTd QTed QTed QTed
Thrombolysed 80.71 93.68 39.28 46.5
NotThrombolysed
72.17 77.95 68.69 73.78
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QT PARAMETERS IN THROMBOLYSED PATENTS  
AND SITE OF INFARCTION
SITE
AT ADMISSION D8 ± 2
















Total 80.71 93.68 39.28 46.5
QT PARAMETERS AND SITE OF INFARCTION IN NOT
THROMBOLYSED PATENTS  
SITE
AT ADMISSION D8 ± 2












Total 72.17 77.95 68.69 73.78
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TABLE :4 AGE AND SITE OF INFARCTION 















































TABLE 5:AGE & QT PARAMETERS IN THROMBOLYSED PATIENTS  
AGE
AT ADMISSION D8±2































IN NOT THROMBOLYSED PATIENTS
AGE
AT ADMISSION D8±2

































1.Composition of the Study Population
A total of 102 patients were taken up for the study.Of these 56 patients were 
treated  with  thrombolytic  therapy  and  46  patients  were  not  treated  with 
thrombolytic therapy.There were 92 males (90%) and 10 females(10%),Anterior 
wall  infarction  constituted  49%,extensive  anterior  10%  and  inferior  wall 
41%.There were only 6 patients with NSTEMI.
2.Age and QT parameters
The QT parameters were correlated among different age groups.  The QT 
parameters  showed  significant  variation  between  the  patients  treated  with 
thrombolytic therapy and  not treated with thrombolytic therapy, in age groups 
40-49,50-59,60-69.The  other  age  groups  did  not  show  significant  statistical 
variation,as the number of patients was small.
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3.QT parameters and Thrombolysis and Site of Infarction.
                       The QT parameters were correlated among study groups and it was 
found that there was significantly greater reductions in QT parameters at day 8±2 
in patients treated with thrombolytic therapy when compared with not treated with 
thrombolytic therapy.It was noted that anterior wall infarction show significantly 
greater  QT,QTc dispersions  when compared with inferior  wall  infarction.These 





It  has  been  suggested  that  QT  dispersion  (maximal  minus  minimal QT 
interval calculated on a standard 12-lead electrocardiogram) could reflect regional 
variations of ventricular repolarization and could provide a substrate for reentry 
ventricular arrhythmias.  Previous studies have proven that successful thrombolysis 
significantly decreases the QT parameters and thereby the arrythmogenic potential 
and  hence  it  decreases  the  risk  of  sudden  cardiac  death  in  patients with  acute 
myocardial infarction.
The present study evaluates QT dispersion in patients with acute myocardial 
infarction treated with thrombolytic therapy when compared with those who were 
not treated with  thrombolytic therapy.  As given in most of the studies cited in the 
review of literature male patients out numbered the females,constituting  90 % of 
the study population . Sex and age of the patients did not influence QT dispersion
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 In the first 3 days QT dispersion was not different in patients treated and 
untreated  with  thrombolysis,  whereas on  day  8±2  it  was  greater  in  untreated 
patients  .When correlated  totally with all walls taken together or individually, 
there were significantly greater reduction in QT,QTc dispersions in patients treated 
with thrombolytic therapy when compared with those who were not treated with 
thrombolytic therapy.   This correlates well  with all  studies depicted (consistent 
with yonus et al ,1996,Paventi.S et al 1994 )
                         The anterior acute myocardial infarction showed  significantly 
greater QT parameters when compared with inferior acute myocardial infarction 
patients  .And  there  was  significantly  greater  reductions  in  QT  parametersin 
patients treated with thrombolytic therapy when compared with those who were 
not  treated  with   thrombolytic  therapy   at  day  8±2  (consistent  with 




1.    There were significantly greater mean QT,QTc dispersions  in the early hours 
of   Acute Myocardial infarction
2. Patients with anterior acute myocardial infarction showed significantly greater 
QT parameters when compared with inferior acute myocardial infarction patients
3. There were significantly greater reduction in QT,QTc dispersions  after 
treatment with streptokinase than without it.
4. QT,QTc dispersions  are greatest in the early hours of acute myocardial 
infarction and fall with time and successful thrombolysis
5.These results can be taken into accont in the risk stratificatiojn for malingnant 
ventricular tachyarrythymias and they are another evidence for the benefit of 
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